The EU financed research- and development programme Eurostars announces an approval for the application which Vicore together with its research partner Charité institute in Berlin applied for in august 2009. Vicore will receive approx. five msek for developmental activities through Vinnova during an 18 month period, given that Vicore will invest the same amount, five msek .
In parallel, the german research ministry granted approx. seven msek to the Charité group for continuing research on Vicore Pharmas substances. This grant does not have a demand for investment from Vicore Pharma since it is a research insitution.
The board at Vicore Pharma are very pleased with this grant. This is positive for us and means that there is a confidence in the technology, and the cooperation with our research partner in Berlin!
Read more about Mintage Scientific and Vicore Pharma on www.mintage.se and www.vicorepharma.com
Tillbaka